CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Operating Expenses:
Research and development	$ 224,026	$ 348,104	$ 854,706	$ 1,097,877
General and administrative	627,575	894,745	1,740,511	2,598,884
Total Operating Expenses	851,601	1,242,849	2,595,217	3,696,761
Operating Loss	(851,601)	(1,242,849)	(2,595,217)	(3,696,761)
Other Income (Expense):
Income from assets held for investment, net (Note 9)				193,607
Interest income		523	11	569
Interest expense	(89,372)	(78,126)	(256,574)	(243,506)
Change in fair value of derivative liabilities (Note 8)	(455,184)	1,591,375	665,491	1,360,818
Gain on extinguishment of debt (Note 4)			327,839
Net Income/(Loss) Before Undernoted	(1,396,157)	270,923	(1,858,450)	(2,385,273)
Minority Interest Share of Loss
Net Income/(Loss)	(1,396,157)	270,923	(1,858,450)	(2,385,273)
Net Loss Available to Common Stockholders	(1,396,157)	(1,149,127)	(1,858,450)	(4,213,602)
Net Loss per Common Share (Note 6) - Basic	$ (0.002)	$ (0.002)	$ (0.002)	$ (0.006)
Net Loss per Common Share (Note 6) - Diluted	$ (0.002)	$ (0.002)	$ (0.002)	$ (0.006)
Basic Shares Used to Compute Earnings per Share (Note 6)	791,855,062	727,041,541	787,175,380	649,133,385
Diluted Shares Used to Compute Earnings/(Loss) per Share (Note 6)	791,855,062	727,041,541	787,175,380	649,133,385
Other Comprehensive Income/(Loss)
Change in foreign currency translation adjustments	(9,553)	(4,613)	(21,682)	(9,633)
Other Comprehensive Income/(Loss)	(9,553)	(4,613)	(21,682)	(9,633)
Comprehensive Income/(Loss)	(1,405,710)	266,310	(1,836,768)	(2,375,640)
Preferred Stock Dividend (Note 7)		1,420,050		1,828,329
Comprehensive Loss Availble to Common Stockholders	$ (1,405,710)	$ (1,153,740)	$ (1,836,768)	$ (4,203,969)